1 – 8 of 8
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations
(
- Contribution to journal › Article
- 2020
-
Mark
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
(
- Contribution to journal › Article
- 2016
-
Mark
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
(
- Contribution to journal › Article
- 2015
-
Mark
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2013
-
Mark
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Coronary Heart Disease in Systemic Lupus Erythematosus Is Associated With Interferon Regulatory Factor-8 Gene Variants
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article